Search research articles
Contact Us
Filters
Showing results (481-490 of 491) with videos related to
Page
of 50
Sort By:
Psycho-Oncology
|
April 26, 2022
Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer
Nathaniel E Davis, Jonathan J Hue, Ravi K Kyasaram, et al.
Journal of Surgical Oncology
|
May 17, 2023
The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases
Yutaka Endo, Belisario Ortiz Rueda, Selamawit Woldesenbet, et al.
Molecular Human Reproduction
|
April 26, 2022
Human pluripotent stem cell-derived cells endogenously expressing follicle-stimulating hormone receptors: modeling the function of an inactivating receptor mutation
K Lundin, K Sepponen, P Väyrynen, et al.
Pharmaceutical Research
|
May 11, 2018
Denaturation and Aggregation of Interferon-τ in Aqueous Solution
Ryan R Manning, Glenn A Wilson, Ryan E Holcomb, et al.
Digestive Diseases and Sciences
|
March 1, 2000
Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival
G Shiota, M Ishida, N Noguchi, et al.
Neurology
|
February 25, 2005
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease
T Hamaguchi, T Kitamoto, T Sato, et al.
Cancer Research Communications
|
May 21, 2026
Increased glucose availability sensitizes pancreatic cancer to macrophage-targeting immunotherapies
Jonathan J Hue, Mehrdad Zarei, Priyashree Sunita, et al.
The British Journal of Dermatology
|
October 26, 2021
Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy
A Hoyer, E M Rehbinder, M Färdig, et al.
Science (New York, N.Y.)
|
September 6, 2005
Antisense transcription in the mammalian transcriptome
S Katayama, Y Tomaru, T Kasukawa, et al.
Nature Cancer
|
June 10, 2022
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
Ali Vaziri-Gohar, Joel Cassel, Farheen S Mohammed, et al.
Page
of 50
Search research articles
Search
Showing results (481-490 of 491) with videos related to
Sort By:
Page
of 50
Psycho-Oncology
|
April 26, 2022
Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer
Nathaniel E Davis, Jonathan J Hue, Ravi K Kyasaram, et al.
Journal of Surgical Oncology
|
May 17, 2023
The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases
Yutaka Endo, Belisario Ortiz Rueda, Selamawit Woldesenbet, et al.
Molecular Human Reproduction
|
April 26, 2022
Human pluripotent stem cell-derived cells endogenously expressing follicle-stimulating hormone receptors: modeling the function of an inactivating receptor mutation
K Lundin, K Sepponen, P Väyrynen, et al.
Pharmaceutical Research
|
May 11, 2018
Denaturation and Aggregation of Interferon-τ in Aqueous Solution
Ryan R Manning, Glenn A Wilson, Ryan E Holcomb, et al.
Digestive Diseases and Sciences
|
March 1, 2000
Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival
G Shiota, M Ishida, N Noguchi, et al.
Neurology
|
February 25, 2005
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease
T Hamaguchi, T Kitamoto, T Sato, et al.
Cancer Research Communications
|
May 21, 2026
Increased glucose availability sensitizes pancreatic cancer to macrophage-targeting immunotherapies
Jonathan J Hue, Mehrdad Zarei, Priyashree Sunita, et al.
The British Journal of Dermatology
|
October 26, 2021
Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy
A Hoyer, E M Rehbinder, M Färdig, et al.
Science (New York, N.Y.)
|
September 6, 2005
Antisense transcription in the mammalian transcriptome
S Katayama, Y Tomaru, T Kasukawa, et al.
Nature Cancer
|
June 10, 2022
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
Ali Vaziri-Gohar, Joel Cassel, Farheen S Mohammed, et al.
Page
of 50